i3 Consult to Expand It's CTR Reporting for Observational Studies in Pre-Approval and Post Marketing for Mobile OS Application
Back in December last year i3 Consult launched its CTRReporting Services for Observational Studies (). Just to re-iterate the unique selling point of these services, i3 Consult through its weekly clinical trial reports (CTR) on new drug therapies currently in clinical trials worldwide, we are seeking to use our CTR database as real world evidence in helping our clients to address the following critical success issues: • Is the research sufficiently patient-focused? • Have sufficient observational studies been used in the pre-approval and post market stages? • Are there further opportunities for observational study data to save you time and money in your current clinical trial investigation? • How observational studies can make a viable alternative to clinical trials or bridging studies. • To identify stakeholders and determine what kind of observational research data is needed. At i3 Consult we believe that